Background: Burkitt's lymphoma is a B-cell neoplasm characterized by a chromosomal translocation involving the c-myc gene. BL may carry, besides the c-myc translocation, several other lesions including a) mutations in c-myc, b) mutations in bcl-6, c) mutations in p53 and d) EBV genomes. In this report we describe a unique study of the timing of these genetic lesions during the evolution and progression of Burkitt's lymphoma.
Introduction
Burkitt's lymphoma (BL) is a diffuse B-cell neoplasm which primarily involves the abdomen or head and neck regions. Infiltration of the marrow in these lymphomas is frequently observed in sporadic BL but is uncommon in endemic BL, in which involvement of the jaw is a prominent feature [1] . The chromosomal translocations, present in all types of BL [2] , are believed to occur in immature B cells, either pre-B or even pro-B cells [3] . It is also likely that other early events in lymphomagenesis take place in progenitor B cells in the marrow. The development of a clinically apparent tumor is preceded by other genetic changes that to some extent may dictate the sites of involvement by influencing the cell's ability to survive in various microenvironments. In this respect, the strong association of jaw tumors with young children in Africa, and of breast involvement in pubertal girls or lactating women provides powerful evidence that tumor cell survival is dependent upon the microenvironment. These considerations also suggest the possibility that the extent and the spectrum of additional genetic lesions may differ in BL at different anatomical locations in the same individual. The essentially universal presence of either a t (8;14) , a t(8;22) or a t(2;8) chromosomal translocation in these neoplasms indicates that the c-myc translocation is a necessary and early event in the genesis of BL [4] . However, several observations attest to the fact that the c-myc translocation is not sufficient in itself to allow the development of a tumor. First, as mentioned above, the c-myc translocation occurs very early in the ontogeny of B cells [3] , even prior to immunoglobulin gene rearrangement, and yet the BL cells are monoclonal for heavy and light Ig chains. Second, the expression of a deregulated c-myc gene in transgenic mice leads to polyclonal precursor B-cell hyperplasia, but also to increased B-cell apoptosis, and monoclonal neoplasms do not develop for six to nine months [5, 6] , almost certainly because other genetic abnormalities are required in this process. In BL, oncogenes that cooperate with c-myc may include those that are always present in BL (e.g., a lesion that may permit escape from apoptosis in a cell containing a deregulated c-myc) or those that are preferentially selected for because they provide a growth or survival advantage in a particular microenvironment such as the marrow, jaw or intestine.
BL may carry, besides the c-myc translocation, several other lesions including a) mutations in the c-myc protein that can abrogate the repressive function of plO7 [7, 8] , b) point mutations in the regulatory region of the bcl-6 repressor oncogene, specially in HIV associated BL [9, 10] , and c) mutations in p53 that allow the tumor cell to become chemoresistant, although their presence prior to chemotherapy suggests that these mutations are relevant to tumor progression (i.e., ability to survive in various microenvironments) [11] [12] [13] . Indeed, the tumorigenic potential of BL in nude mice appears to correlate with the presence o£p53 mutations [14] .
An additional lesion that is present in several BL biopsies at varying frequencies, depending upon geography, is the presence of the EBV genome [15] . Data derived from both in situ hybridization and Southern blotting strongly suggest that EBV infection takes place prior to the clonal expansion of the cells [16] , but this does not speak to whether the translocation or EBV infection occurs first.
In this report we have determined the spectrum of genetic lesions present in cells isolated from multiple lymphoma masses biopsied from the same individual both synchronously and metachronously. Our data indicate that c-myc translocation and bcl-6 mutations, if present, are indeed early events and that there is an ongoing acquisition of secondary lesions in the myc and p53 proteins that can differ in BL cells obtained from different sites. In one BL from an HIV infected individual, we have also demonstrated differences in the EBV episome present in cell clones isolated from either the marrow, pleural effusion or from circulating BL cells.
Materials and methods

Patients and cell lines
Both patients were treated in the Pediatric Oncology Branch at the National Cancer Institute, Bethesda, MD, USA. One of the patients, a four-year-old boy, presented with disseminated BL. At the time of diagnosis (Feb. 79) cell lines were established from two different isolates: ascites and bone marrow (JDasc and JDbm, respectively). Ten months later the patient relapsed and a third cell line was established from a sample of peripheral blood (JDpb) containing BL cells. The patient subsequently died from progressive tumor.
The second patient, a 30-year-old male infected with HIV, also presented with widespread BL. Three separate cell lines were established at this time (June 82), from different sites, bone marrow, peripheral blood and pleural effusion (PAbm, PApb and PApe, respectively). The patient died with disease.
All cell lines were grown in RPMI 1640 medium containing 50 ug/ ml streptomycin and penicillin and supplemented with 20% fetal calf serum, at 37 °C in an atmosphere with 5% CO2.
Molecular studies
Southern blot analyses
Genomic DNA was prepared from cell lines by standard proteinase K digestion, phenol: chloroform purification and ethanol precipitation. DNA was digested with EcoRI, Hindlll, BamHI, PstI, PvuII and Smal, electrophoresed into 0.8% agarose gels, transferred to nylon membranes and hybridized with probes from the J H , Su and Cu regions of IgH and with exon 1 and exon 3 probes from c-myc. Technical details have been previously published [17] . The presence of EBV was determined by Southern blotting after digestion of genomic DNA with BamHI and hybridization with a viral probe from the terminal repeat region. Clonality of EBV was also examined by LYDMA PCR analysis as previously described [18] .
Amplification and sequencing of the CDRIHregion
This hypervariable region of the IgH gene was amplified by PCR using a consensus sense primer derived from the variable region (5'CGAGGA CACGGCCGTGTATTACTGT 3') and a consensus antisense primer derived from the joining region (5'AACTGCTGAGGAGACGGT-GACCA 3'). The PCR product for each cell line was gel-purified and directly sequenced using Sequenase 2.0 (USB, Cleveland, OH). To confirm the data, a different, overlapping fragment was amplified by semi-nested PCR using a primer from framework 2 (5' TGGA/ GTCCGC/ACAGG/CCT/CCNGG 3') and a joining consensus primer (5' ACCTGAGGAGACGGTGACCAGGGT 3' in the first round, and 5' CAGGGTCCCTTGGCCCCAG 3 1 in the reamplification).
SSCP analyses
The entire c-myc coding sequences were studied by SSCP as previously reported [7] . The PCR products that displayed abnormally migrating bands were directly sequenced as described. Similarly, exons 4-11 of the p53 gene were screened by SSCP and sequenced [11] . SSCP analysis of multiple PCR fragments spanning the regulatory region of bcl-6 (nucleotides +4 to +1142) was performed as previously reported [10] . Samples scored positive by the PCR-SSCP assay were further studied by DNA direct sequencing of the PCR amplified product using the Thermo Sequenase radiolabeled terminator cycle sequencing kit (Amersham, Cleveland, OH) according to the manufacturer's instructions.
Cell cycle analysis
Cells were washed in ice-cold PBS and fixed with 70% ethanol. Immediately before study, the cells were washed in PBS and treated with RNAse (500 units/ml). DNA was stained with propidium iodide and the DNA content distribution was determined using a Becton Dickinson flourescence-activated cell analyzer.
Results
JD series
The origin of all three JD cell lines was confirmed by HLA typing, determined as Al, B8, BW35 and HLA class II as DRB1: 0402, 1301; DQB1: 03**, 0603; DRB4: IgH alleles is interrupted by the juxtaposition of c-myc, indicating that these cell lines, like 60% of BLs [3] , carry only one productively rearranged IgH allele. This VDJ rearrangement appears to be the same in the two cell lines established at diagnosis (asc and bm), but the rearranged band in the cell line from relapse (pb) migrated differently ( Figure 2 ). In order to determine whether the difference in the size of the IgH rearranged band in the cell line JDpb, represented a unique VDJ recombination or, alternatively, whether the difference resulted from a further evolution of the same VDJ recombination, we used PCR to amplify the CDRIII region from each of the three cell lines and sequenced the amplified products ( Table 2 ). The three cell lines were shown to carry the same hypervariable sequence with only one base difference (G to A) in the relapse sample. Consequently, all the cell lines were derived from the same precursor BL clone. The relapse sample has probably undergone secondary rearrangements in the IgH locus which would account for the different pattern in Southern blot.
Since we have previously established that a high proportion of BLs express mutations in the coding region of c-myc [7] , we examined the c-myc gene from each of the cell lines. SSCP and direct PCR sequence analyses (Table 1) showed an identical mutation (TTC-TCC) that results in substitution of a phenylalanine by a serine at amino acid 138 in all three cell lines. In addition, the JDbm cell line has a silent mutation (GCC-GCT) at position 96. We obtained identical results from the earliest passage of JDbm.
Another genetic abnormality frequently detected in a subset of BLs is mutations in the 5' non-coding region of the bcl-6 oncogene [9, 10] . The SSCP analysis of the regulatory region of bcl-6 included three overlapping PCR fragments which, between them, contain >95% of the mutations previously observed in AIDS-NHL and DLCL. As shown in Table 1 , all three cell lines were wild type by this analysis. We have previously shown that a high proportion of BLs carry p53 mutations [11] . We, therefore, analyzed the integrity of the p53 gene by SSCP and sequence analyses and also determined the functional status of p53 in these cell lines by studying the capability of the cells to undergo Gl arrest following DNA damage. As shown in Table 1 and Figure 3 , all three cell lines carry a mutated p53 gene. However, each cell line is hemi/ homozygous for a different p53 mutation with a varying ability to undergo Gl arrest after radiation induced DNA damage (Table 1) . Analysis of p53 mutations was also carried out from different passages of the cell lines, including passages frozen at the time of establishment, with identical results.
The tumor (from both sites at diagnosis, and at relapse) was characterized as EBV negative by the absence of EBNA-1 staining of lymphoma cells. The established cell lines were also EBV negative as confirmed by Southern blot analysis using a terminal repeat EBV probe (data not shown).
PA series
The origin of these cell lines was also confirmed by HLA typing. PAbm, PApb and PApe were characterized as (Figure 2) . However, sequence analysis of the CDRIII region in each case showed this hypervariable region of the IgH chain to be identical in all three cell lines (Table 2) . Therefore, as in the JD series, the three cell lines were derived from the same precursor BL clone but underwent further evolution of the IgH rearrangement, resulting in a change in the restriction pattern.
SSCP and subsequent sequence analyses of the entire coding region of the c-myc gene showed that these cell lines carry multiple point mutations (Table 1) . Codons 35 and 36 underwent the same silent mutation (CAG-CAA), whereas mutations at codons 44 (GCG-GTG) and 58 (ACC-GCC) resulted in substitutions of alanine by valine, and threonine to alanine, respectively. All these changes were present in all three cell lines, confirming their identical clonal origin. We also detected additional changes that were not shared by all the cell lines, suggesting that mutations of c-myc are an ongoing event. For example, in codon 40 (CTG) there is a silent mutation (TTG) in PApb but a substitution of leucine to serine (TCG) in PAbm and PApe. In addition, amino acid 70 codes for a tyrosine (TAC) instead of a cysteine (TGC) in the PApe cell line, but not in the other two PA cell lines.
SSCP analysis of the regulatory region of bcl-6 showed identically migrating aberrant bands for all three cell lines, PAbm, PApb and PApe, in two of the three fragments analyzed ( Figure 4 and Table 1 ). Sequencing demonstrated that all three cell lines harbored a heterozygous G-C transversion at nucleotide 684 and a C-T transition at nucleotide 1079 (Figure 4) . As observed in the cell lines derived from patient JD, the integrity of the p53 gene in the PA series of cell lines was discordant. The single mutation observed occurred in one allele in PApe at codon 248 (arginine to glutamine) as shown in Table 1 and Figure 3 . This mutation abolished the ability of the cells to undergo Gl arrest after irradiation. Neither PApb nor PAbm carried mutations in p53 (exons 4-11) although PApb failed to undergo Gl arrest following DNA damage ( Table 1) .
The three cell lines, like the original tumor, were all associated with EBV, but surprisingly, they differed with respect to the hybridizing band(s) representing the terminal repeats region of the EBV episome. As shown in VNTR of 33 bp. Two cell lines, PAbm and PApe, displayed the same sized PCR products, suggesting again that they are infected by the same virus. On the other hand, PApb showed a different size band for the LYD-MA region which, together with the Southern blot data, indicate an independent EBV infection.
Discussion
Lymphomas are considered to be an expansion of neoplastic lymphoid cells that originate from a single precursor cell. It is, however, clear that, like other tumors, lymphomas carry multiple genetic lesions [19] . Thus, although the genetic defects of the parent precursor lymphocyte in which the neoplastic transformation was completed will be present in all the cells in the ensuing tumor, lesions secondary to the primary transforming events will be present in a subset of the cell population containing the primary lesions. In low grade lymphomas that transform to a high grade tumor, for example, the secondary lesion(s) clearly provides the impetus for the clonal expansion of the aggressive lymphoma [20] . On the other hand, the role of secondary genetic lesions in the evolution of primary lymphomas that are aggressive per primum is not clear. Although these lesions must provide some growth advantage, because clones with the lesion are selected for, their exact contribution to the evolution of the clinical disease is not completely understood. Mutations in the p53 gene, in the context of small non cleaved cell lymphomas, appear to provide chemoresistance [13] but since one third of such lymphomas have a p53 mutation at the time of diagnosis [11] , it is likely that this secondary lesion provides other survival advantages besides chemoresistance. In support of this is the observation that the ability of BL cells to proliferate in nude mice, correlates with the presence of p53 mutations [14] . We have also shown that mutations in p53 correlate with relapse [12 and unpublished data] and therefore, as in other lymphomas, they may be associated with transformation to an even more aggressive phenotype.
The present study provides several insights into the molecular evolution of BL. In two series of lymphomaderived cell lines we have obtained from two patients, it is clear that each of the separate clones from each patient contain the same c-myc translocation, indicating that this is one of the defining events for transformation. As we have previously shown, at the time of, or very close to this event, the precursor B cell undergoes a productive rearrangement in one IgH allele. In all the cell lines from each patient the CDRIII analysis indicates that the cell lines are also clonal with respect to the Ig locus. In Southern blot analysis of the Ig gene rearrangements, we have not always found concordance between rearranged bands in the separately isolated cell lines from the same patient, but in view of sequence homogeneity in hypervariable regions this must have resulted from somatic mutations that cause change in restriction sites, as has been described, for example, in follicular lymphomas and ALL [21, 22] .
The BL progenitor cell in the process of transformation acquires a series of genetic lesions, including mutations in the bcl-6 and c-myc genes. We found that all cell lines for each patient have the same bcl-6 status (wild type in JD and the same heterozygous mutation in PA) suggesting that this, too, is an early, or defining event in lymphomagenesis. It has been previously reported that a high proportion of AIDS-related BLs carry mutations in the regulatory region of bcl-6, suggesting that such mutations are a critical factor in AIDS-lymphomagenesis [9, 10] . Further, the presence of at least a common subset of c-myc mutations in the BL cells isolated from various sites would indicate that these mutations are of importance in the clonal expansion of the lymphoma -a suggestion supported by the demonstration that such mutations may contribute to the deregulation of c-myc function [8] . The presence of additional, unique mutations in the c-myc coding region suggests that these mutations are ongoing. It is unlikely that the mutagenic influence relates to genetic instability resulting from loss of p53 function since several of the clones with discordant p53 mutations show similar c-myc mutations, strongly suggesting that mutations in c-myc occurred prior to the mutations in p53. Moreover, the absence of overexpression of p53 in all cells in a tumor supports the likelihood that/755 mutations are late events, i.e., arise after transformation has been completed.
One of the cell line series in this report (PA) was derived from an EBV positive BL arising in a patient with AIDS. In one of the cell lines established from the various sites (PApb), the EBV termini in the EBV episome gave rise to a different sized band and heterogeneity was also observed in the LYDMA region. These data are consistent with two possibilities: either EBV infection occurred as a post-transformation event, as previously suggested in another AIDS-BL by Roncella [23] , or the EBV genome undergoes rearrangements after infection of the precursor BL cell and clonal expansion. If EBV was indeed a late event in this lymphoma, however, the presence of EBV in all three clones, supports the necessity of the virus in the development of clinical disease in this patient.
It is apparent from this study, as anticipated, that tumors manifested at different sites all derive from the same transformed cell, since they carry the same translocation and the same Ig rearrangement. It is also clear, however, that the original clone of transformed cells develops other genetic lesions, specifically mutations that result in modulation of the hypervariable region of the Ig gene, and ongoing mutations in the c-myc gene. Moreover, clones derived from different sites carry different p53 mutations. This suggest that the mutations arise in the clones that originally seed each site since if the tumor were heterogeneous with respect to p53 mutations prior to spreading, the tumors at each site would also be heterogeneous with respect to/7.53.
We can, therefore, order the occurrence of some of the genetic lesions present in BL cells. The presence of a common CDRIII sequence, a common c-myc translocation and a common bcI-6 status in separate cell clones from the same patient emphasizes that the c-myc translocation and bcl-6 mutations occur early in BL lymphomagenesis. Since only a subset of c-myc mutations are common to all the clones within an individual patient, it is conceivable that the c-myc mutations also occur early but are an ongoing event. The discordance in the p53 mutations suggests that p53 mutations occur later, and are not necessarily essential to transformation. Finally, in the case of the HIV associated BL, it appears that EBV infection may sometimes, at least, occur subsequent to the c-myc translocation, mutations within the c-myc coding region and mutations of bcl-6 regulatory regions.
